Isavuconazonium sulfate

(Cresemba®)

Isavuconazonium sulfate

Drug updated on 11/16/2023

Dosage FormCapsule (oral; 186 mg); Injection (intravenous; 372 mg)
Drug ClassAzole antifungals
Ongoing and
Completed Studies
ClinicalTrials.gov

Indication

  • For the treatment of adults with invasive aspergillosis or invasive mucormycosis.